3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
1
Genetic Diseases, Inborn
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Oxaliplatin
6
tislelizumab
3
Irinotecan
3
Fluorouracil
3
Chemotherapy, Adjuvant
3
Capecitabine
3
sintilimab
2
raltitrexed
2
pembrolizumab
2
Surgical Procedures, Operative
2
Specimen Handling
2
Neoadjuvant Therapy
2
HMPL-013
2
spartalizumab
1
rimegepant sulfate
1
encorafenib
1
cemiplimab
1
balstilimab
1
XELOX
1
Surgical Fixation Devices
1
Radiofrequency Ablation
1
Propranolol
1
Preoperative Exercise
1
Pemetrexed
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mortality
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Laparoscopy
1
Immune Checkpoint Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Colonic Neoplasms
×
Diagnostic Tests, Routine
×
Clear all
NCT06990633
2025-05-25
LYNX
Izmir Ataturk Training and Research Hospital
Not yet recruiting
180 enrolled